IM
Ilko Menkov Portfolio
Invests via Vestal Point Capita LLP | Managed by Ryan Wilder
Invests via Vestal Point Capita LLP
Managed by Ryan Wilder
Automatically Tracked
Ilko Menkov Profile
With a robust background in strategic investments and financial management, Ilko Menkov is an influential figure within the European private equity landscape. His expertise encompasses extensive operational leadership, particularly in technology and innovation sectors, where he has played a pivotal role in scaling startups and driving sustainable growth. Leveraging deep market insights, he collaborates closely with entrepreneurs to enhance business models that foster resilience and expansion. This focus on value creation has established him as a respected investor-operator who continuously seeks transformative opportunities across various markets.
With a robust background in strategic investments and financial management, Ilko Menkov is an influential figure within the European private equity landscape. His expertise encompasses extensive operational leadership, particularly in technology and innovation sectors, where he has played a pivotal role in scaling startups and driving sustainable growth. Leveraging deep market insights, he collaborates closely with entrepreneurs to enhance business models that foster resilience and expansion. This focus on value creation has established him as a respected investor-operator who continuously seeks transformative opportunities across various markets.
Investment Philosophy & Strategy
Grounded in an extensive history of entrepreneurial ventures, Ilko Menkov applies a unique blend of operational insights and strategic foresight to his investment endeavors. His approach is primarily driven by identifying disruptive trends within technology sectors, enabling him to cultivate promising startups poised for exponential growth. By prioritizing partnerships with visionary founders, he aligns resources and expertise to optimize scalability and impact. This emphasis on transformative potential allows him to capitalize on market dynamics while fostering innovation that drives competitive advantage.
Grounded in an extensive history of entrepreneurial ventures, Ilko Menkov applies a unique blend of operational insights and strategic foresight to his investment endeavors. His approach is primarily driven by identifying disruptive trends within technology sectors, enabling him to cultivate promising startups poised for exponential growth. By prioritizing partnerships with visionary founders, he aligns resources and expertise to optimize scalability and impact. This emphasis on transformative potential allows him to capitalize on market dynamics while fostering innovation that drives competitive advantage.
Disclaimer: This Portfolio is derived from and computed based on publicly available data from SEC filings.
Gain and growth charts are calculated per selected timeframe:
50.23%
Gain +0.16%
Monthly
1.39%
Yearly
18.03%
Drawdown
39.86%
$3.4B
Equity
Holdings
$3.4B
Investment
$3.11B
$1.01B
Profit +$5.72M
Realized
$713.73M
Unrealized
$293.57M
Dividends
$8.82M
Goals
Avg. 0% completed goals
Yearly
Gain > 5% 2026
Yearly
Gain < 20% 2026
Today
Compared To Yesterday
Gain
0.16%
Profit
$5.72M
Win %
56%
This Week
Compared To Last Week
Gain
-0.11%
Profit
-$3.7M
Win %
56%
This Month
Compared to last month
Gain
-1.79%
Profit
-$62.16M
Win %
56%
This Year
Compared to last year
Gain
-25.64%
Profit
-$671.05M
Win %
60%
ELVN Enliven Therapeutics, Inc.
+14.3%
+$18.75M 
ZBIO Zenas BioPharma, Inc.
+11.49%
+$408,000 
RAPP Rapport Therapeutics Inc.
+9.06%
+$4.58M 
RVMDW Revolution Medicines, Inc. Warrant
+7.51%
+$985,625 
TENX Tenax Therapeutics Inc.
+6.99%
+$40,079.25 
ARVN Arvinas Inc.
+6.91%
+$443,677.85 
GLUE Monte Rosa Therapeutics, Inc.
+6.64%
+$4.09M 
RGNX Regenxbio Inc.
+6.05%
+$41,239.5 
TRVI Trevi Therapeutics Inc.
+5.57%
+$1.62M 
TYRA Tyra Biosciences, Inc.
+5.55%
+$76,680 
CADL Candel Therapeutics Inc.
+4.9%
+$450,000 
ABSI Absci Corporation
+4.46%
+$67,343.51 
CLDX Celldex Therapeutics Inc.
+4.37%
+$1.6M 
LXEO Lexeo Therapeutics Inc.
+4.05%
+$760,750 
PASG Passage Bio Inc.
+3.75%
+$64,050 
IMTX Immatics N.V.
+3.53%
+$1.98M 
ZURA Zura Bio Ltd.
+3.35%
+$61,320 
TECX Tectonic Therapeutic Inc.
+3.2%
+$308,320 
DNLI Denali Therapeutics Inc.
+3.04%
+$1.13M 
QURE uniQure N.V.
+2.8%
+$269,247 
AGIO Agios Pharmaceuticals Inc.
+2.58%
+$333,000 
BCRX BioCryst Pharmaceuticals Inc.
+2.35%
+$1.41M 
TSHA Taysha Gene Therapies Inc.
+2.33%
+$2.34M 
SGP SpyGlass Pharma, Inc.
+1.94%
+$233,366 
BCAX Bicara Therapeutics Inc.
+1.93%
+$2.22M 
VERA Vera Therapeutics Inc.
+1.81%
+$834,576.99 
ZBH Zimmer Biomet Holdings, Inc.
+1.64%
+$271,700 
COGT Cogent Biosciences, Inc.
+1.47%
+$590,826.24 
MDGL Madrigal Pharmaceuticals, Inc.
+1.37%
+$204,227.32 
DYN Dyne Therapeutics Inc.
+1.34%
+$960,000 
CYTK Cytokinetics, Incorporated
+1.27%
+$264,000 
OLMA Olema Pharmaceuticals Inc.
+1.23%
+$51,426.12 
IMCR Immunocore Holdings plc American Depositary Receipt
+1.19%
+$940,735.12 
VYGR Voyager Therapeutics Inc.
+1.16%
+$120,117.44 
MNPR Monopar Therapeutics Inc.
+1.14%
+$44,157.15 
ASND Ascendis Pharma A/S
+1.14%
+$922,500 
GEHC GE HealthCare Technologies Inc.
+1.04%
+$167,500 
GERN Geron Corporation
+0.88%
+$25,400 
URGN Urogen Pharma Ltd.
+0.75%
+$30,597.38 
BMRN Biomarin Pharmaceutical Inc.
+0.73%
+$1.45M 
INSP Inspire Medical Systems, Inc.
+0.61%
+$140,209.94 
ALC Alcon Inc.
+0.51%
+$272,000 
VKTX Viking Therapeutics Inc.
+0.49%
+$127,980.58 
BMY Bristol-Myers Squibb Company
+0.4%
+$230,000 
NVCR NovoCure Ltd.
+0.4%
+$17,500 
PODD Insulet Corporation
+0.34%
+$25,806.51 
SNY Sanofi American Depositary Receipt
+0.32%
+$196,000 
NKTR Nektar Therapeutics Inc.
+0.29%
+$48,450 
ANRO Alto Neuroscience Inc.
+0.19%
+$82,563 
REGN Regeneron Pharmaceuticals, Inc.
+0.11%
+$26,400 
UTHR United Therapeutics Corporation
+0.1%
+$42,000 
SRZN Surrozen, Inc.
+0.09%
+$6,772.22 
APRE
0%
$0 
ARWR
0%
$0 
AZN
0%
$0 
GLTO Galecto Inc.
0%
$0 
KALV KalVista Pharmaceuticals Inc.
0%
$0 
SLNO Soleno Therapeutics, Inc.
0%
$0 
TERN Terns Pharmaceuticals, Inc.
0%
$0 
MPLT MapLight Therapeutics, Inc.
-8.57%
-$1.09M 
NYXH Nyxoah SA
-6.71%
-$86,866.1 
MYGN Myriad Genetics Inc.
-6.48%
-$494,400 
ABVX Abivax SA ADR
-4.28%
-$6.48M 
PALI Palisade Bio Inc.
-3.93%
-$175,000 
FULC Fulcrum Therapeutics Inc.
-2.82%
-$110,000 
CBIO Crescent Biopharma, Inc.
-2.29%
-$630,000 
RGEN Repligen Corporation
-2.06%
-$2.53M 
NBIX Neurocrine Biosciences Inc.
-1.81%
-$3.69M 
WGS GeneDx Holdings Corp.
-1.75%
-$267,500 
AVR Anteris Technologies Ltd.
-1.72%
-$183,164.8 
APGE Apogee Therapeutics Inc.
-1.31%
-$1.29M 
MGNX Macrogenics Inc.
-1.25%
-$14,000 
ENGN enGene Therapeutics Inc.
-1.22%
-$43,300 
OKUR OnKure Therapeutics Inc.
-1.18%
-$91,990.95 
WAT Waters Corporation
-1.17%
-$421,000 
SRRK Scholar Rock Holding Corporation
-1.14%
-$675,455.22 
SLDB Solid Biosciences Inc.
-1.11%
-$400,000 
BBNX Beta Bionics Inc.
-1.09%
-$353,842.88 
TARS Tarsus Pharmaceuticals Inc.
-1.05%
-$132,000 
DRUG Bright Minds Biosciences Inc.
-1.01%
-$305,237.78 
BSX Boston Scientific Corporation
-0.55%
-$208,000 
WST West Pharmaceutical Services, Inc.
-0.46%
-$114,000 
SVRA Savara Inc.
-0.19%
-$26,000.52 
VCYT Veracyte Inc.
-0.19%
-$11,761.83 
NRIX Nurix Therapeutics Inc.
-0.18%
-$195,000 
XENE Xenon Pharmaceuticals Inc.
-0.17%
-$57,591 
NUVL Nuvalent, Inc.
-0.16%
-$96,343 
GMED Globus Medical Inc.
-0.16%
-$79,367.6 
IRON Disc Medicine Inc.
-0.13%
-$63,000 
PTGX Protagonist Therapeutics Inc.
-0.01%
-$3,261.59 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 625 | Longs Won 261/625 41% | Profit Factor 2.8 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $8.36M |
| Average Win $6M | Best Trade (Jun 14) $82.05M | Sharpe Ratio -7 |
| Average Loss -$1.53M | Worst Trade (Jun 14) -$34.47M | Z-Score -2.68 (100%) |
| Commissions $0 | Avg. Trade Length 7m 2w 3d | Expectancy $1.61M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,217 | 1,996 | 1,774 | 1,552 | 1,330 | 1,109 | 887 | 665 | 443 | 222 |
Hover over the desired column for a detailed explanation.
Returns
Overall, MonthlyNo Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
